Global Low-Density Lipoprotein Cholesterol—Leveraging Estimation for Action
The Global Burden of Disease (GBD) 2023 study represents another step in the laudable, collective effort to better understand the causes of health, disease, and mortality around the world in a comprehensive and cohesive manner. The article in this issue of JAMA by the GBD 2023 LDL Cholesterol Collaborators reports trends in the global, regional, and national burden of cardiovascular disease (CVD) attributed to elevated low-density lipoprotein cholesterol (LDL-C) from 1990 to 2023. The study addr...
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.